Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock

Pediatric Critical Care Medicine

Volumn 5, Issue 2, 2004, Pages 116-118

  Matok, Ilan ^a   Leibovitch, Leah ^a   Vardi, Amir ^a   Adam, Miriam ^a   Rubinshtein, Marina ^a   Barzilay, Zohar ^a   Paret, Gideon ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Catecholamines; Child; Hypotension; Infant; Neonate; Pediatric; Septic shock; Terlipressin

Indexed keywords

CATECHOLAMINE; DRUG DERIVATIVE; LYPRESSIN; TERLIPRESSIN; VASOCONSTRICTOR AGENT;

ARTICLE; BLOOD PRESSURE; CASE REPORT; DRUG EFFECT; ENTEROBACTER INFECTION; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; SEPTIC SHOCK;

BLOOD PRESSURE; CATECHOLAMINES; HUMANS; HYPOTENSION; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; KLEBSIELLA INFECTIONS; LYSINE VASOPRESSIN; MALE; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 3843087518     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/01.PCC.0000112521.93714.B8     Document Type: Article

References (11)

1. Ben-Abraham R, Hadad E, Weinbroum AA, et al: Vasopressin in cardiac arrest and vasodilatory shock: A forgotten drug for a new indication. Isr Med Assoc J 2003; 5:272-276
2. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588-595
3. Tsuneyoshi I, Yamada H, Kakihana Y, et al: Hemodynamic and metabolic effects of lowdose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29: 673-675
4. Rosenzweig EB, Starc TJ, Chen JM, et al: Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999; 100(19 Suppl):II182-II186
5. Holmes CL, Patel BM, Russell JA, et al: Physiologyof vasopressin relevant to management of septic shock. Chest 2001; 120: 989-1002
6. Westphal M, Stubbe H, Sielenkamper AW, et al: Terlipressin dose response in healthy and endotoxemic sheep: Impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 2003; 29: 301-308
7. O'Brien A, Clapp L, Singer M: Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359:1209-1210
8. Scharte M, Meyer J, Van Aken H, et al: Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001; 29: 1756-1760
9. Meersschaert K, Brun L, Gourdin M, et al: Terlipressin-ephedrine versus ephedrine to treat hypotension at the induction of anesthesia in patients chronically treated with angiotensin converting enzyme inhibitors: A prospective, randomized, double-blinded, crossover study. Anesth Analg 2002; 94: 835-840
10. Hadengue A, Gadano A, Moreau R, et al: Beneficial effects of 2 day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 1998; 29: 565-570
11. Solanki P, Chawla A, Garg R, et al: Beneficial effects of terlipressin in hepatorenal syndrome: A prospective, randomized placebocontrolled clinical trial. J Gastroenterol Hepatol 2003; 18:152-156